BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2167148)

  • 21. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures.
    Ajiki T; Onoyama H; Yamamoto M; Fujimori T; Maeda S; Saitoh Y
    Int J Pancreatol; 1995 Dec; 18(3):215-20. PubMed ID: 8708392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.
    Malats N; Porta M; Piñol JL; Corominas JM; Rifà J; Real FX
    J Clin Oncol; 1995 Jul; 13(7):1679-86. PubMed ID: 7602358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
    Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
    Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas.
    Grünewald K; Lyons J; Fröhlich A; Feichtinger H; Weger RA; Schwab G; Janssen JW; Bartram CR
    Int J Cancer; 1989 Jun; 43(6):1037-41. PubMed ID: 2659539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
    Hruban RH; Sturm PD; Slebos RJ; Wilentz RE; Musler AR; Yeo CJ; Sohn TA; van Velthuysen ML; Offerhaus GJ
    Am J Pathol; 1997 Oct; 151(4):943-9. PubMed ID: 9327727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of ras gene mutations of primary hepatic malignant tumors by polymerase chain reaction and direct sequencing method].
    Tada M; Omata M; Ohto M
    Nihon Shokakibyo Gakkai Zasshi; 1990 Mar; 87(3):811-5. PubMed ID: 2167400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
    Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
    J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of K-ras codon 12 and 13 mutations found in pancreatic adenocarcinoma of 30 Chinese patients by microdissection, PCR and direct sequencing.
    Wei S; Liang Z; Gao J; Wu S; Zhu H; Liu H; Liu T
    J Gastroenterol Hepatol; 2005 Jan; 20(1):67-72. PubMed ID: 15610449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reassessment of K-ras mutations at codon 12 by direct PCR and sequencing from tissue microdissection in human pancreatic adenocarcinomas.
    Aoki Y; Hosaka S; Tachibana N; Karasawa Y; Kawa S; Kiyosawa K
    Pancreas; 2000 Aug; 21(2):152-7. PubMed ID: 10975709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma.
    Motojima K; Urano T; Nagata Y; Shiku H; Tsurifune T; Kanematsu T
    Ann Surg; 1993 Feb; 217(2):138-43. PubMed ID: 8439212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Absence of Ki-ras mutations in exocrine pancreatic tumors from male rats chronically exposed to gabapentin.
    Fowler ML; Sigler RE; de la Iglesia FA; Reddy JK; Lalwani ND
    Mutat Res; 1995 Mar; 327(1-2):151-60. PubMed ID: 7870083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
    Hanada K; Tsuchida A; Iwao T; Eguchi N; Sasaki T; Morinaka K; Matsubara K; Kawasaki Y; Yamamoto S; Kajiyama G
    Am J Gastroenterol; 1999 Jun; 94(6):1638-42. PubMed ID: 10364037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
    Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
    Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts.
    Iwase T; Nakazawa S; Yamao K; Yoshino J; Inui K; Yamachika H; Kanemaki N; Fujimoto M; Okushima K; Miyoshi H; Taki N; Nakamura Y; Mizutani S; Horibe Y; Masui T; Tatematsu M
    Hepatogastroenterology; 1997; 44(17):1457-62. PubMed ID: 9356872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
    Tada M; Omata M; Ohto M
    Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct.
    Hanada K; Itoh M; Fujii K; Tsuchida A; Ooishi H; Kajiyama G
    Cancer; 1996 Feb; 77(3):452-8. PubMed ID: 8630951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.